Building the future of preventative health, from discovery to Europe
Kihealth Europe is the European chapter of a story that began with scientific discovery in the United States and now extends to clinicians, researchers, and patients across the continent.
A new vision for preventative healthcare
For decades, healthcare has been built around diagnosing disease after symptoms appear. Kihealth was founded on a different belief: that the future of medicine lies in identifying biological changes earlier, enabling intervention before irreversible damage occurs.
- 01Symptoms
- 02Diagnosis
- 03Treatment
- 01Biological change
- 02Early detection
- 03Intervention
- 04Improved outcomes
Precision medicine, molecular diagnostics, and healthy aging — together.
A technology platform rooted in pioneering diabetes research
The foundational scientific concepts behind the Kihealth platform originated from research focused on understanding beta-cell biology and the biological processes associated with diabetes progression. The company was built upon years of scientific investigation rather than a simple commercial concept.
- 01
Academic research
Beta-cell biology investigated in university laboratories.
- 02
Scientific discovery
Biological signals identified before traditional clinical markers shift.
- 03
Technology development
Discovery translated into proprietary assay platforms.
- 04
Clinical translation
Signals characterized across the disease continuum with research partners.
- 05
Commercialization
Platform brought to clinicians, researchers, and patients.
From Yale research to commercial reality
The foundational concepts behind the Kihealth platform trace back to groundbreaking diabetes research conducted at Yale University, where investigators sought to better understand beta-cell biology and the progression of diabetes at the cellular level.
These discoveries helped inspire a new generation of diagnostic thinking — one focused on the biological processes occurring before traditional clinical markers become abnormal, and on the cellular events that precede measurable disease.
- Scientific credibility
Decades of peer-reviewed beta-cell biology.
- Translational medicine
Bench discovery moved into clinical context.
- Academic roots
Built with university and hospital collaborators.
- Innovation
A new lens on metabolic disease detection.
Built and commercialized in the United States
Transforming scientific innovation into clinical reality.
Kihealth Labs, headquartered in St. Augustine, Florida, serves as the company's scientific, operational, and commercial foundation — the engine powering platform development from discovery through scale.
- Research and development
- Laboratory operations
- Clinical studies
- Academic collaborations
- Commercial diagnostic services
The Intercept IQ™ platform
A new approach to understanding metabolic disease. Kihealth's vision extends beyond a single test — the platform is designed to generate deeper biological insight into metabolic health and diabetes progression over time.
Biological signals associated with Type 1 diabetes onset and progression.
Insight into the cellular events behind Type 2 diabetes development.
Longitudinal signal designed to inform prevention and intervention windows.
A platform architected for additional metabolic health applications over time.
Expanding the future of preventative healthcare across Europe
Europe faces a growing burden of diabetes, obesity, metabolic dysfunction, and chronic disease. Healthcare systems increasingly recognize the value of prevention, early detection, and precision medicine. Kihealth Europe was established to bring advanced metabolic diagnostics and preventative health technologies to providers, researchers, institutions, employers, and patients throughout Europe.
Karolinska Institutet · Karolinska University Hospital
Headquartered in Milan, Italy
Connecting innovation, healthcare, and European growth. Milan was selected as the European commercial hub for Kihealth's expansion across the continent.
- Strategic location
Central position within the European healthcare landscape.
- Innovation ecosystem
Anchor to one of Europe's leading healthcare clusters.
- Research institutions
Proximity to top academic and clinical centers.
- Gateway to markets
Direct routes into every major European economy.
- Business infrastructure
International commercial and regulatory access.
To help transform healthcare from a reactive system focused on disease management into a proactive system focused on prevention, early detection, and improved long-term health outcomes.
Building the future of metabolic health
Kihealth Europe represents the next chapter in a vision that began with scientific discovery, evolved through clinical innovation, and now seeks to expand across Europe. By combining advanced diagnostics, molecular biology, and preventative medicine, Kihealth is helping build a future where disease is understood earlier, intervention occurs sooner, and healthcare becomes more proactive, personalized, and effective.